About 100 reports

" CUPID## and CUPID## fall within new class of genes called long noncoding RNAs.

  • Hospital
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • Social Conditions

" There is likely a good reason why genes that make RNAs rather than proteins exist.

  • Cancer
  • Medical Biotechnology
  • Specialty Hospital
  • Therapy
  • United States

Cancers that produced a small molecule of RNA called MIR## seemed able to resist treatment more than those with low levels.

  • Breast Cancer
  • Specialty Hospital
  • United Kingdom
  • Cancer Research Technology Limited
  • Merck Serono S.A.

Each unit consists of one share of common stock and one warrant to purchase a share of common stock at an exercise price of USD##. ## per share.

  • Molecular Diagnostics
  • Specialty Hospital
  • United States
  • Company
  • Cancer Genetics, Inc.

Rna Diagnostics is headquartered in Toronto, Ontario, Canada.

  • Clinical Trial
  • Drug Development
  • Specialty Hospital
  • United States
  • Company

" This paper provides a molecular blueprint for RNA-targeted genetic engineering, says Salk Assistant Professor Dmitry Lyumkis, a structural biologist and one of the corresponding authors of the study.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • Aug 11, 2017: Ohio State Cancer Researchers Validate a Clinical Test For Fusion Genes

Dec ##, 2017: Researchers invent novel RNA nanotech to decorate exosomes for effective cancer therapy A new study shows that attaching antibody-like RNA nanoparticles to microvesicles can deliver effective RNA therapeutics such as small interfering RNA (siRNA) spe

  • Health Services
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • Deals & Alliance

The prominent features of this report are - ##.

  • Clinical Trial
  • Oncology
  • Specialty Hospital
  • United States
  • World

MicroRNAs are short segments of RNA encoded on the chromosomes of cells.

  • Ambulatory Care
  • Health Services
  • Hospital
  • Specialty Hospital
  • United States

The RNA pieces, called " long non-coding RNAs" or " lncRNAs, " help skin cells modulate connective tissue proteins, like collagen, and could represent novel therapeutic targets to promote skin repair.

  • Health Services
  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States

The INTERCEPT Blood System leverages the fact that blood components do not require functional DNA or RNA, as opposed to pathogens and donor white blood cells.

  • Blood Supply
  • Clinical Trial
  • Hospital
  • Specialty Hospital
  • CytoSorbents Corporation

The team hopes to use small molecules called ASOs (antisense oligonucleotides) that can bind to RNA, to change the way AFMID' s RNA messages are spliced.

  • Clinical Trial
  • Hepatitis
  • Liver Cancer
  • Specialty Hospital
  • Pfizer Inc.

Rimonim focuses on the chemistry and delivery of RNA-based drugs for treating cancer.

  • Drug Development
  • Specialty Hospital
  • United States
  • Product Initiative
  • PolyPid, Ltd.

We then used a high-throughput genetic screening approach that investigates the role of thousands of genes simultaneously by blocking their expression with short hairpin RNAs.

  • Specialty Hospital
  • Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.

One of the prominent players in the market is ITF Pharma.

  • Specialty Hospital
  • North America
  • United States
  • World
  • Forecast

Such tests are used to analyze DNA and RNA biomarkers as well as many cellular pathways in different cancers.

  • Specialty Hospital
  • World
  • GE Healthcare Limited
  • Illumina, Inc.
  • QIAGEN N.V.

The prominent features of this report are - ##.

  • Brain Cancer
  • Clinical Trial
  • Hospital
  • Specialty Hospital
  • Merck & Co., Inc.

## ## ## ## Syndax Pharmaceuticals Inc ## ## ## ## Pharmaceutical Product Development LLC ## ## ## ## Mesoblast Ltd ## ## ## ## Johnson & Johnson ## ## ## ## Jiangsu Hansoh Pharmaceutical Group Co Ltd ## ## ##

  • Blood Disease
  • Chemotherapy
  • Specialty Hospital
  • World
  • Product Initiative

The drug targets polo-like kinase ## (PLK-##).

  • Leukemia
  • Specialty Hospital
  • United States
  • Product Initiative
  • Onconova Therapeutics, Inc.

For this study, we will be collecting RNA-seq, SNP, and CNV data from our own patient samples.

  • Pharmaceutical
  • Specialty Hospital
  • Therapy
  • United States
  • Cocrystal Pharma, Inc.

His research project is titled " Understanding the regulatory roles of long non-coding RNAs in lung cancer. "

  • Cancer
  • Specialty Hospital
  • Therapy
  • United States
  • Dana-Farber Cancer Institute, Inc.
  • NANOSTRING ENTERS INTO CO-DEVELOPMENT AGREEMENT WITH MD ANDERSON CANCER CENTER
  • SIGNAL GENETICS ENTERS INTO RESEARCH AGREEMENT WITH UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER

It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases.

  • Cancer
  • Specialty Hospital
  • United States
  • Deals & Alliance
  • RaySearch

GlobalData ANGLE Plc reported one pharmaceuticals & healthcare deal worth $##. ## million in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • Company

Rimonim focuses on the chemistry and delivery of RNA-based drugs for treating cancer.

  • Drug Development
  • Specialty Hospital
  • United States
  • Product Initiative
  • PolyPid, Ltd.
  • Clinical Trial profile. 77 Trial Title
  • Clinical Trial profile. 755 Trial Title

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Astellas Pharma Inc ## ## ## ## ## ## ## ## Takeda Pharmaceutical Co Ltd ## ## ## ## ## ## ## ## Incyte Corp ## ## ## ## ## ## ## ## Bellicum Pharmaceuticals Inc ## ##

  • Monoclonal Antibody
  • Pharmaceutical
  • Specialty Hospital
  • United States
  • World

Hoffmann-La Roche Ltd ## ## ## ## ## ## E.

  • Brain Cancer
  • Specialty Hospital
  • Therapy
  • World
  • Product Initiative

Trials conducted by companies in Phase III, Phase II and Phase I stand at ##, ## and ## respectively.

  • Leukemia
  • Specialty Hospital
  • Therapy
  • World
  • TRACON Pharmaceuticals, Inc.

The prominent features of this report are - ##.

  • Cancer
  • Specialty Hospital
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Blood Disease
  • Cell Therapy
  • Specialty Hospital
  • World
  • Celgene Corporation

The prominent features of this report are - ##.

  • Oncology
  • Specialty Hospital
  • Therapy
  • World
  • Product Initiative